Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma.
Where this comes from
- Record sourced from PubMed, PMID 34357397.
- Also identified by DOI 10.1001/jamanetworkopen.2021.19934 and PMC identifier 8346939.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.
Medical subject headings
- Immune Checkpoint Inhibitors
- Mesothelioma, Malignant
- Peritoneal Neoplasms